#USA #Boston #Molecular Diagnostics #Fapon

Fapon to Showcase Innovative Molecular Diagnostic Solutions

Fapon, a leading organization in the life sciences sector, is set to exhibit its revolutionary molecular diagnostic solutions at the AMP 2025 Annual Meeting and Expo. This highly anticipated event will take place in Boston from November 11 to 15, 2025. Fapon aims to highlight its cutting-edge enzymes that significantly enhance molecular testing processes.

During the expo, Fapon will present a range of products designed to power various molecular diagnostic technologies, including quantitative PCR (qPCR), reverse transcription quantitative PCR (RT-qPCR), isothermal amplification, and Next-Generation Sequencing (NGS) library preparation. This impressive lineup includes:

• - MeloScript Reverse Transcriptase: This enzyme exhibits superior adaptability to target sequences, remarkable tolerance to inhibitors, and impressive thermal stability, making it highly sensitive for various applications.
• - ProPrime Taq DNA Polymerase: Known for its ultra-fast amplification capabilities, this polymerase offers exceptional resistance to inhibitors and high sensitivity, essential for quick and precise diagnostics.
• - PreciAmp Bst DNA Polymerase: This enzyme is engineered for rapid LAMP amplification, providing quick results with high sensitivity and strong inhibitor tolerance, making it ideal for point-of-care testing.
• - NextGen Universal FS DNA Library Prep Kit: This kit facilitates uniform enzymatic fragmentation, improving genome coverage and compatibility across various sample types, while also ensuring fast and automation-friendly library construction.

Beyond product showcases, Dr. Nick Guan, Vice President of Molecular Diagnostics Research and Development at Fapon Biotech, will lead a corporate workshop titled "Shaping the Future of Molecular Testing: Innovative Enzymes at the Core" on November 12, 2025. This session promises to explore how advancements in enzyme engineering are driving the evolution of PCR, NGS, and isothermal amplification technologies. Attendees will gain insights into the future landscape of molecular diagnostics and the role Fapon is playing in this rapidly advancing field.

Fapon’s presence at the AMP meeting underscores its commitment to enhancing molecular diagnostics with high-quality, innovative products. The company has further reinforced its dedication to the U.S. market by establishing a research and development center in Boston, which focuses on enzyme innovation, alongside a local warehouse designed to streamline customer support.

Fapon isn't just about leading in molecular diagnostics; it's about redefining the research and development paradigm within the diagnostics and therapeutics sectors through advanced methodologies including an "AI-driven + closed loop of dry and wet experiments" model. This unique approach accelerates the discovery of novel biomarkers and translates them more efficiently into applicable solutions. Their innovative products span the entire spectrum of health management, driving forward progress in precision medicine.

For those interested in scheduling a meeting with Fapon during the AMP 2025 Annual Meeting, they can reach out via email at [email protected].

To stay updated with Fapon's latest innovations and insights, follow them on LinkedIn or visit their official website at Fapon Biotech.

Fapon's revolutionary approach is setting new benchmarks in the field of molecular diagnostics, paving the way for future innovations that have the potential to transform health management practices globally.